FDA.reportPublic FDA data

aripiprazole 400 MG Injection

RxCUI
1659812
RxNorm name
aripiprazole 400 MG Injection
Display name
aripiprazole 400 MG Injection
Full name
aripiprazole 400 MG Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ABILIFY MAINTENAARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.ee49f3b1-1650-47ff-9fb1-ea53fe0b92b62026-03-24Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1659812

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6ARIPiprazole 400 MG Extended Release Injection [PSN] · aripiprazole 400 MG Injection [SCD]227These highlights do not include all the information needed to use ABILIFY MAINTENA safely and effectively. See full prescribing information for ABILIFY MAINTENA. ABILIFY MAINTENA ® (aripiprazole) for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 200220260324